1. Home
  2. NVCT vs MVBF Comparison

NVCT vs MVBF Comparison

Compare NVCT & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • MVBF
  • Stock Information
  • Founded
  • NVCT 2020
  • MVBF 1997
  • Country
  • NVCT United States
  • MVBF United States
  • Employees
  • NVCT N/A
  • MVBF N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • MVBF Major Banks
  • Sector
  • NVCT Health Care
  • MVBF Finance
  • Exchange
  • NVCT Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • NVCT 249.1M
  • MVBF 205.7M
  • IPO Year
  • NVCT 2022
  • MVBF N/A
  • Fundamental
  • Price
  • NVCT $8.98
  • MVBF $19.21
  • Analyst Decision
  • NVCT Strong Buy
  • MVBF Buy
  • Analyst Count
  • NVCT 3
  • MVBF 3
  • Target Price
  • NVCT $17.00
  • MVBF $24.67
  • AVG Volume (30 Days)
  • NVCT 132.1K
  • MVBF 28.6K
  • Earning Date
  • NVCT 05-06-2025
  • MVBF 07-28-2025
  • Dividend Yield
  • NVCT N/A
  • MVBF 3.54%
  • EPS Growth
  • NVCT N/A
  • MVBF N/A
  • EPS
  • NVCT N/A
  • MVBF 1.46
  • Revenue
  • NVCT N/A
  • MVBF $146,101,000.00
  • Revenue This Year
  • NVCT N/A
  • MVBF N/A
  • Revenue Next Year
  • NVCT N/A
  • MVBF $14.06
  • P/E Ratio
  • NVCT N/A
  • MVBF $13.15
  • Revenue Growth
  • NVCT N/A
  • MVBF N/A
  • 52 Week Low
  • NVCT $4.44
  • MVBF $15.59
  • 52 Week High
  • NVCT $11.80
  • MVBF $25.24
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.39
  • MVBF 59.72
  • Support Level
  • NVCT $9.92
  • MVBF $19.55
  • Resistance Level
  • NVCT $11.15
  • MVBF $19.95
  • Average True Range (ATR)
  • NVCT 0.64
  • MVBF 0.59
  • MACD
  • NVCT -0.09
  • MVBF 0.03
  • Stochastic Oscillator
  • NVCT 26.94
  • MVBF 72.59

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

Share on Social Networks: